Sharepoint Solutions
PRODUCTS
-
ProPharma has built the world’s leading and first full-service global solution dedicated to Advertising & Promotional Review.
-
Werum PAS-X as a Service delivers a fully managed, cloud-based MES for pharma and biotech, enabling rapid deployment, scalability, cost savings, compliance, and operational efficiency.
-
Early Phase Experts
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
With a broad range of experience delivering Phase 1 Healthy Volunteer, First in Human, First in Patient and Phase 2 trials, we know just how important it is for your asset to succeed in the early development lifecycle. Our experienced team will help you obtain high-quality data that will appeal to future investors, meet the requirements of international regulatory bodies such as the FDA, EMA, PMDA, and Health Canada, and prepare your product for larger Phase 3 and 4 studies, partnerships, licensing, and sale.
Whatever your clinical trial needs, we can provide a flexible, bespoke solution that will not only meet your regulatory requirements but also position your product for commercial success.
-
For just about any water problem, Newterra has you covered. If you’re looking for medium or short-term water or wastewater treatment solutions, Newterra has a large, in-stock inventory of solutions that are available to rent. From supplemental aeration to reverse osmosis systems to pressure vessels and complete wastewater treatment systems, our temporary ownership and rental solutions can save precious capital while solving a critical need. Newterra offers flexible terms and conditions to suit any customer.
-
Clinical trial recruitment solution: Get the right participants for your clinical research study easier and faster than ever before.
WHITE PAPERS AND CASE STUDIES
-
Arkansas, USA | Pulp And Paper Mill
A pulp and paper mill in Arkansas replaced chemical treatments with SDOX systems, resulting in reduced costs, improved odor control, and better water quality. The technology has also shown effectiveness in treating shallow surface waters.
-
The Role Of A Consulting Firm In The IND Process
Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.
-
Quantitation Of Monoclonal Antibodies In Serum
Monoclonal antibodies (mAbs) are a rapidly growing group of targeted therapeutics. Gain insight into the importance of optimized bioanalytical assay platforms for mAb development.
-
Hospital-Based eCOA Implementation: Real Challenges In Infectious Disease Trials
This resource outlines proven strategies to reduce delays, improve compliance, and meet regulatory standards for PRO data in infectious disease studies.
-
Authentic Engagement: Reaching Underserved Lupus Patients
By partnering with the ICLF, see how we were able to gain access to and build trust with influential community leaders and advocates within the African American communities located near study sites.
-
FDA Recommendations For Gene Therapy For PMDs
Explore insight into the strategies and FDA recommendations for executing gene therapy development programs, specifically for primary mitochondrial diseases (PMDs).
-
Designing, Selecting, And Developing Bioconjugates For Clinical Success
Accelerate the development of complex bioconjugates to unlock new possibilities for targeted therapies and advance the next generation of precision medicine.
-
Expert Guidance For EU Gene Therapy And Companion Diagnostic Trial Regulations
This playbook provides a concise yet comprehensive roadmap for navigating Europe’s multifaceted regulatory environment when conducting gene therapy trials involving GMOs and CDx.
-
A Strategic Guide For Biotech And Biopharma Leaders
Securing drug approval is a complex, high-stakes process, and outdated review workflows hinder progress. Explore modern solutions that accelerate timelines without compromising compliance or quality.
-
Customer Story: Emergent BioSolutions Enhances Aseptic Filling Process
Upgrading outdated filling systems is essential for meeting future production demands and regulatory standards. Learn how one manufacturer modernized its approach to ensure compliance and efficiency.
-
Removing Translation Bottlenecks With AI
See how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.
-
Gene Therapy For Mitochondrial Disease: A Guide To Emerging Regulation
Learn how the FDA's expedited programs, along with the efforts of innovative companies, are paving the way for the development of effective gene therapies to address primary mitochondrial diseases.
NEWS
-
H2APEX And Copenhagen Infrastructure Partners Enter Into Strategic Partnership For Pioneering Hydrogen Project In Lubmin8/5/2025
H2APEX Group SCA announces that Copenhagen Infrastructure Partners (CIP) – one of the world’s leading investment companies in energy infrastructure investments – has acquired a majority stake of 70% in the first phase of H2APEX’s IPCEI-funded hydrogen project in Lubmin through its Energy Transition Fund (CI ETF I) as a strategic investor.
-
Global Hydrogen Market: Uniper And thyssenkrupp Uhde Sign Framework Agreement On The Use Of Ammonia Cracking Technology11/26/2025
Uniper and thyssenkrupp Uhde have signed a framework agreement that lays the foundation for the construction of commercial ammonia cracking plants.
-
Diasorin Submits The LIAISON NES Point-Of-Care Molecular Diagnostics System And 4-Plex Respiratory Panel To The FDA For 510(k) Clearance And CLIA Waiver7/2/2025
Diasorin announces the submission of a 510(k) premarket notification and CLIA waiver application to the U.S. Food and Drug Administration (FDA) for its LIAISON NES, a next-generation molecular POC testing platform.
-
Investigating The 'Glue' That Holds Cells Together3/20/2025
Northwestern Medicine investigators have uncovered new insights into how intercellular “glue” functions to enable interactions between cells, as detailed in a study published in Nature Communications.
-
Kruger Products Inaugurates New LDC Plant In Sherbrooke6/9/2025
Kruger Products Inc. today inaugurated its new LDC (light dry crepe) tissue plant in Sherbrooke, constructed on a site adjacent to its TAD plant.